Pharmaceutical drugs supplied by: Shorla Oncology Inc.
✉ Email this page to a colleague
Shorla Oncology Inc.
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Shorla | TEPYLUTE | thiotepa | SOLUTION;INTRAVENOUS | 216984 | NDA | Shorla Oncology Inc. | 81927-105-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-105-01) / 1.5 mL in 1 VIAL, SINGLE-DOSE | 2025-03-31 |
| Shorla | TEPYLUTE | thiotepa | SOLUTION;INTRAVENOUS | 216984 | NDA | Shorla Oncology Inc. | 81927-106-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (81927-106-01) / 10 mL in 1 VIAL, MULTI-DOSE | 2025-03-31 |
| Shorla | NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 214809 | ANDA | Shorla Oncology Inc. | 81927-111-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-01) / 50 mL in 1 VIAL, SINGLE-DOSE | 2023-03-15 |
| Shorla | NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 214809 | ANDA | Shorla Oncology Inc. | 81927-111-06 | 6 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-06) / 50 mL in 1 VIAL, SINGLE-DOSE | 2023-03-15 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
